Dr. Ranjeeta Chand, MD

Dr. Chand practices at Methodist Hospital (TX) in San Antonio, Texas.

Dr. Chand's NPI, 1750735437, was assigned on April 19, 2016. Dr. Chand graduated from Peoples University of Medical and Health Sciences - Nawabshah in 2009. Dr. Chand holds Texas license T6855.

Dr. Chand's primary practice is Methodist Hospital (TX), at 7700 Floyd Curl Dr, San Antonio, TX 78229 in Bexar County. The practice phone is (210) 575-4000.

Dr. Chand's primary practice is Methodist Hospital (TX) in San Antonio, Texas. Dr. Chand is also affiliated with Methodist Hospital. The medical group on file is Methodist Healthcare System. Dmand AI also links Dr. Chand to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chand practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Chand's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Chand is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Chand's licenses on file in 3 states: Texas, Illinois and New York.

Dmand AI lists chronic kidney disease among the conditions Dr. Chand treats.

CMS data shows 338 Medicare services from Dr. Chand across 5 procedure codes in 2024, for 108 Medicare patients. Medicare paid $29,627 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 108 Medicare patients who saw Dr. Chand in 2024. The largest group is under 65, with 73 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 29% are also on Medicaid. Their average risk score is 6.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chand's median patient age at 55, with 47% women.

In 2024, Dr. Chand wrote 775 Medicare Part D claims for 184 patients. 87% of them were for generic drugs. CMS names the drug for 568 of them, across 22 drugs with 11 or more claims each, at $32,309 in total drug cost. In 2023, CMS named 906 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Chand for performance year 2024, reported as part of a group. Dr. Chand accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Chand in 2024. Dr. Chand's most frequent co-authors are David S. Goldfarb, MD, Matthias H. Kapturczak, MD and Tamer Mahmoud Shaker.

CMS Open Payments shows 34 general payments to Dr. Chand from 10 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 94% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $442.

Dr. Chand graduated from Peoples University of Medical and Health Sciences - Nawabshah in 2009.

Dr. Chand is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.